We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Prevalence and impact of depression in chronic obstructive pulmonary disease patients.
Current Opinion in Pulmonary Medicine 2006 March
PURPOSE OF REVIEW: This review presents recent advances in the study of the depression that is so often co-morbid with chronic obstructive pulmonary disease. The discussion includes prevalence, etiology, impact and management.
RECENT FINDINGS: Efforts continue to find a reliable prevalence rate for co-morbid depression in patients with chronic obstructive pulmonary disease but studies regularly find depression in 20-60% of these patients. Multiple etiologies contribute to this elevated rate including genetic predisposition, grief reaction, and effects of chronic obstructive pulmonary disease on the central nervous system. Once depression develops patients are less adherent to treatment plans, lose function and, potentially, suffer worse outcomes in exacerbations. Management of depression in chronic obstructive pulmonary disease continues to be primarily empirical. There are few quality studies demonstrating the usefulness of antidepressants in this population. Some studies suggest selective serotonin reuptake inhibitors will be effective, but require replication in larger groups. Other interventions including psychotherapy, physical rehabilitation, and improved social support are accumulating supporting data, but further research is needed.
SUMMARY: Depression is present in up to 60% of patients with chronic obstructive pulmonary disease. It jeopardizes patients' ability to utilize treatment and may increase their risk for poor outcomes. Effective management will require high-quality studies and a multidisciplinary approach.
RECENT FINDINGS: Efforts continue to find a reliable prevalence rate for co-morbid depression in patients with chronic obstructive pulmonary disease but studies regularly find depression in 20-60% of these patients. Multiple etiologies contribute to this elevated rate including genetic predisposition, grief reaction, and effects of chronic obstructive pulmonary disease on the central nervous system. Once depression develops patients are less adherent to treatment plans, lose function and, potentially, suffer worse outcomes in exacerbations. Management of depression in chronic obstructive pulmonary disease continues to be primarily empirical. There are few quality studies demonstrating the usefulness of antidepressants in this population. Some studies suggest selective serotonin reuptake inhibitors will be effective, but require replication in larger groups. Other interventions including psychotherapy, physical rehabilitation, and improved social support are accumulating supporting data, but further research is needed.
SUMMARY: Depression is present in up to 60% of patients with chronic obstructive pulmonary disease. It jeopardizes patients' ability to utilize treatment and may increase their risk for poor outcomes. Effective management will require high-quality studies and a multidisciplinary approach.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app